OBGYN oral board OP2.1A: Managing side effects of tamoxifen and aromatase inhibitor

Managing the side effects of oral aromatase inhibitorsПодробнее

Managing the Side Effects of Aromatase Inhibitors and TamoxifenПодробнее

Women & Cancer – Aromatase Inhibitors & Tamoxifen 101Подробнее

What is the Difference Between Aromatase Inhibitors and Tamoxifen?Подробнее

Side Effects of Aromatase Inhibitors, Tamoxifen and RaloxifeneПодробнее

Professor Mitch Dowsett - Tamoxifen vs Aromatase InhibitorsПодробнее

Side Effects of Aromatase Inhibitors, From a Medical Oncologist's ViewПодробнее

What is the Difference Between Aromatase Inhibitors and Tamoxifen?Подробнее

Management of the Side Effect of Hormone Therapy (Seung Ah Lee)Подробнее

Switching From Aromatase Inhibitors To TamoxifenПодробнее

How Does Tamoxifen Work for Breast Cancer?Подробнее

Adjuvant Endocrine Therapy and Risk of Contralateral Breast CancerПодробнее

Dr. Joseph Sparano on the Role of Endocrine Therapy in Breast CancerПодробнее

HER2 status as predictive marker for aromatase inhibitor versus tamoxifen use in early breast cancerПодробнее

ASK UNMC. Tomoxifen and breast cancer.Подробнее

What to do in a high risk early BC patient who has poor tolerance to ovarian function suppression ?Подробнее

OBGYN oral board OB3.2M: Intrapartum management of intraamniotic infectionПодробнее

Ovarian Suppression and Bone Management in Breast CancerПодробнее

San Antonio Breast Cancer Symposium 2008: BIG 1-98: Letrozole vs tamoxifenПодробнее